Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics.
作者信息
Khan Mohd Wajid Ali, Aziz Mohammad Azhar, Rajendrasozhan Saravanan
机构信息
Department of Chemistry, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
Medical and Diagnostic Research Centre, University of Ha'il, Ha'il, Saudi Arabia.
出版信息
Front Immunol. 2023 Aug 22;14:1270182. doi: 10.3389/fimmu.2023.1270182. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics.社论：免疫疗法与小分子抑制剂作为联合癌症治疗手段
Front Immunol. 2023 Aug 22;14:1270182. doi: 10.3389/fimmu.2023.1270182. eCollection 2023.
2
Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies.社论：癌症的联合免疫疗法：新靶点、机制与策略
Front Immunol. 2023 Aug 11;14:1250975. doi: 10.3389/fimmu.2023.1250975. eCollection 2023.
3
Editorial: Community series in combinational immunotherapy of cancer: novel targets, mechanisms, and strategies, volume II.社论：癌症联合免疫疗法中的社区系列：新靶点、机制与策略，第二卷
Front Immunol. 2023 Aug 11;14:1256691. doi: 10.3389/fimmu.2023.1256691. eCollection 2023.
4
Macrocyclic Compounds from Ansamycin Antibiotic Class as Inhibitors of PD1-PDL1 Protein-Protein Interaction.来自安莎霉素类抗生素的大环化合物作为PD1-PDL1蛋白质-蛋白质相互作用的抑制剂
Chem Pharm Bull (Tokyo). 2018;66(8):773-778. doi: 10.1248/cpb.c17-00800.
5
Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy.靶向细胞程序性死亡受体 1（PD-1）及其配体（PD-L1）：癌症主动免疫治疗的新纪元。
Pharmacol Ther. 2019 Feb;194:84-106. doi: 10.1016/j.pharmthera.2018.09.008. Epub 2018 Sep 28.
6
Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy.CD73-腺苷能检查点抑制剂作为常规和先进癌症免疫疗法的有前途的联合治疗药物。
Front Immunol. 2023 Jun 26;14:1212209. doi: 10.3389/fimmu.2023.1212209. eCollection 2023.
7
Mechanism-directed combinational immunotherapies in liver cancer hold promise.针对肝癌的机制导向性联合免疫疗法前景广阔。
Cell Mol Immunol. 2023 Nov;20(11):1395-1397. doi: 10.1038/s41423-023-01068-z. Epub 2023 Aug 7.
8
Small-Molecule Drugs in Immunotherapy.免疫疗法中的小分子药物。
Mini Rev Med Chem. 2023;23(13):1341-1359. doi: 10.2174/1389557522666220930154527.
9
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.DPP 抑制改变了 CXCR3 轴，增强了自然杀伤细胞和 CD8+T 细胞浸润，从而提高了胰腺导管腺癌小鼠模型中抗 PD-1 的疗效。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-002837.
10
[Immunotherapy in non-small cell lung cancer: inhibition of PD1/PDL1 pathway].[非小细胞肺癌中的免疫疗法：PD1/PDL1 通路的抑制]
Rev Pneumol Clin. 2015 Feb;71(1):44-56. doi: 10.1016/j.pneumo.2014.11.004. Epub 2015 Feb 14.
Zotero 插件